Literature DB >> 32452874

Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation.

Hakeem Yusuff1,2, Vasileios Zochios1,3, Daniel Brodie4.   

Abstract

Year:  2020        PMID： 32452874      PMCID： PMC7268818          DOI： 10.1097/MAT.0000000000001208

Source DB:  PubMed          Journal:  ASAIO J        ISSN： 1058-2916            Impact factor:   2.872


× No keyword cloud information.
  21 in total

Review 1.  Contact system revisited: an interface between inflammation, coagulation, and innate immunity.

Authors:  A T Long; E Kenne; R Jung; T A Fuchs; T Renné
Journal:  J Thromb Haemost       Date:  2016-02-09       Impact factor: 5.824

Review 2.  Extracorporeal life support: the precarious balance of hemostasis.

Authors:  G M Annich
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

3.  Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.

Authors:  P Lukito; A Wong; J Jing; J F Arthur; S F Marasco; D A Murphy; P J Bergin; J A Shaw; M Collecutt; R K Andrews; E E Gardiner; A K Davis
Journal:  J Thromb Haemost       Date:  2016-10-20       Impact factor: 5.824

4.  Multi-Modal Characterization of the Coagulopathy Associated With Extracorporeal Membrane Oxygenation.

Authors:  Tiago Granja; Kurt Hohenstein; Patricia Schüssel; Claudius Fischer; Thomas Prüfer; David Schibilsky; Hans Peter Wendel; Karl Jaschonek; Lina Serna-Higuita; Christian Schlensak; Helene Häberle; Peter Rosenberger; Andreas Straub
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

Review 5.  Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components.

Authors:  Andrew J Doyle; Beverley J Hunt
Journal:  Front Med (Lausanne)       Date:  2018-12-12

Review 6.  Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease.

Authors:  Jae C Chang
Journal:  Thromb J       Date:  2019-05-30

7.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

8.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Authors:  Julie Helms; Charles Tacquard; François Severac; Ian Leonard-Lorant; Mickaël Ohana; Xavier Delabranche; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Florence Fagot Gandet; Samira Fafi-Kremer; Vincent Castelain; Francis Schneider; Lélia Grunebaum; Eduardo Anglés-Cano; Laurent Sattler; Paul-Michel Mertes; Ferhat Meziani
Journal:  Intensive Care Med       Date:  2020-05-04       Impact factor: 17.440

9.  Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.

Authors:  Robert H Bartlett; Mark T Ogino; Daniel Brodie; David M McMullan; Roberto Lorusso; Graeme MacLaren; Christine M Stead; Peter Rycus; John F Fraser; Jan Belohlavek; Leonardo Salazar; Yatin Mehta; Lakshmi Raman; Matthew L Paden
Journal:  ASAIO J       Date:  2020-05       Impact factor: 2.872

10.  Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.

Authors:  Yingchun Zeng; Zhongxiang Cai; Yunyan Xianyu; Bing Xiang Yang; Ting Song; Qiaoyuan Yan
Journal:  Crit Care       Date:  2020-04-15       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.